[A new cardiac pacemaker stimulation technology (autocapture) allows, with unchanged life expectancy, reduction of generator size by half].
Energy delivery (stimulation amplitude) of a pacemaker should be adjusted to the depolarisation threshold of the heart, which is a nonconstant magnitude. As programming of the stimulation amplitude is time-consuming, many pacemakers are never adjusted to the measured threshold referring to energy delivery. The unnecessary energy loss subsequently reduces the longevity of the implanted devices and remains the weak point of modern pacemakers. Autocapture function (automatic stimulation threshold search, subsequently automatic amplitude regulation 0.3 V above measured threshold, evoked response detection to verify the efficacy of every stimulus and back up pulse in case of loss of capture) is for the first time realized in an extremely small, rate adaptive, multiprogrammable single chamber pacemaker (Microny SR+ 2425T). The pulse generator was tested in a multicentric, european clinical investigation study. These pacemakers were implanted in 8 patients (5 male, 3 female) between December 1994 and April 1995. Automatic measurement of Autocapture threshold revealed 0.7 +/- 0.15 V at implantation, 1.5 +/- 0.3 V after 1 month, 1.3 +/- 0.14 V after 6 months and 1.3 +/- 0.14 V 1 year after implantation. A safety margin of 0.3 V is added to the threshold value to secure capture, therefore mean stimulation amplitude is 1.6 V after 12 months implantation time. The Autocapture feature minimizes current drain and that means that this extremely small generator provides a comparable life as the twice as large common generators used at present time.
Antretter
H
H
Abteilung für Herzchirurgie, I. Chirurgischen Universitätsklinik Innsbruck.
Bonatti
J
J
Cottogni
M
M
Hangler
H
H
Müller
L C
LC
Mair
P
P
Dapunt
O E
OE
D000368:Aged; D001281:Atrial Fibrillation / Q000209:etiology / Q000628:therapy; D001919:Bradycardia / Q000209:etiology / Q000628:therapy; D004562:Electrocardiography / Q000295:instrumentation*; D004867:Equipment Design; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D012804:Sick Sinus Syndrome / Q000209:etiology / Q000628:therapy; D012815:Signal Processing, Computer-Assisted / Q000295:instrumentation*; D012984:Software
Eine neue Herzschrittmacher-Stimulationstechnologie (Autocapture) ermöglicht bei unveränderter Lebensdauer die Reduktion der Generatorgrösse auf die Hälfte.